Genscript Biotech

Genscript Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genscript Biotech (1548.HK) as of Sep 25, 2026 is 255.25 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.18 M USD — a change of 21,468.45% (higher).

EBITDA

255.25 MUSD

YoY

21,468.45%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genscript Biotech is 2026 255.25 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genscript Biotech was 2025 1.18 M USD. It decreases by 21,468.45% higher compared to the previous year.

The Genscript Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
6.69 M USD
Jan 1, 2019
-131.35 M USD
Jan 1, 2020
-204.55 M USD
Jan 1, 2021
-494.00 M USD
Jan 1, 2022
-55.86 M USD
Jan 1, 2023
3.34 M USD
Jan 1, 2024
1.18 M USD
Jan 1, 2025
255.25 M USD
The Genscript Biotech EBITDA history
YEAREBITDAYoY
255.25 MUSD+21,468.45%
1.18 MUSD-64.56%
3.34 MUSD-105.98%
-55.86 MUSD-88.69%
-494.00 MUSD+141.51%
-204.55 MUSD+55.73%
-131.35 MUSD-2,062.73%
6.69 MUSD-83.25%
39.94 MUSD+58.57%
25.19 MUSD+127.60%
11.07 MUSD+53.92%
7.19 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genscript Biotech is 255.25 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genscript Biotech changed from 1.18 M USD to 255.25 M USD, representing a 21,468.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Genscript Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genscript Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genscript Biotech